Question 1

What is Bristol-Myers Squibb — Celgene?

Accepted Answer

Bristol-Myers Squibb — Celgene is a Entity.

Question 2

How often does Bristol-Myers Squibb — Celgene appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Bristol-Myers Squibb — Celgene first tracked by Ergen?

Accepted Answer

First tracked on May 01, 2026.

Question 4

When was Bristol-Myers Squibb — Celgene last mentioned in news?

Accepted Answer

Last active on May 01, 2026.

Question 5

What is Bristol-Myers Squibb — Celgene's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Bristol-Myers Squibb — Celgene in global news coverage?

Accepted Answer

Attention score of 8, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Bristol-Myers Squibb — Celgene?

Accepted Answer

Biotech M&A Surges Amid Patent Cliffs (May 01, 2026, 6 articles).

Question 8

How did the "Biotech M&A Surges Amid Patent Cliffs" event impact Bristol-Myers Squibb — Celgene?

Accepted Answer

Bristol-Myers Squibb — Celgene was acquired by Bristol Myers Squibb in a mega-merger that significantly contributed to the high M&A value in 2019, serving as a benchmark for the current dealmaking pace.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.